0 calificaciones0% encontró este documento útil (0 votos)
3K vistas11 páginas
Omeros, one of Seattle’s biggest biotech companies, is in the midst of a contentious legal battle with its former chief business and commercial officer, who the company alleges violated his non-compete agreement when he left for a Boston-area company that is developing a potentially competing drug.
Omeros, one of Seattle’s biggest biotech companies, is in the midst of a contentious legal battle with its former chief business and commercial officer, who the company alleges violated his non-compete agreement when he left for a Boston-area company that is developing a potentially competing drug.
Omeros, one of Seattle’s biggest biotech companies, is in the midst of a contentious legal battle with its former chief business and commercial officer, who the company alleges violated his non-compete agreement when he left for a Boston-area company that is developing a potentially competing drug.
Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 1 of 11
Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 2 of 11
Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 3 of 11 Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 4 of 11 Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 5 of 11 Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 6 of 11 Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 7 of 11 Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 8 of 11 Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 9 of 11 Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 10 of 11 Case 2:18-cv-00908-RAJ Document 8 Filed 06/21/18 Page 11 of 11